Skip to main content

Table 1 Main characteristics of 207 patients with locoregional breast cancer

From: Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer

Characteristics N %
Total   207 100
Age (range) 56 (30-88)
Tumor size   
  T1 121 58,50%
  T2 76 36,70%
  T3-T4 10 4,80%
Lymph node   
  Negative 106 51,20%
  Positive 101 48,80%
Histology   
  Ductal 173 83,60%
  Lobular 24 11,60%
  Other 10 4,80%
Tumor grade (Scarff-Bloom-Richardson)   
  1 52 25,10%
  2 96 46,40%
  3 59 28,50%
Estrogen receptor   
  Negative 53 25,60%
  Positive 153 73,90%
Progesterone receptor   
  Negative 61 29,50%
  Positive 145 70,00%
Her2-neu expression (IHC)   
  0, 1+ or 2+ 182 87,90%
  3+ 22 10,60%
  Unknown 3 1,40%
CCR6 expression on Tumor cells   
  Negative 130 64,4%
  Positive 72 35,6%
CCR7 expression on Stromal cells   
  Negative 118 57,0%
  Positive 89 43,0%
CCL19 expression on Tumor cells   
  Negative 95 46,6%
  Positive 109 53,4%
CCL19 expression on Dendritic cells   
  Negative 103 50,5%
  Positive 101 49,5%
  1. IHC: assessed by immunohistochemistry.